# Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012

> **NCT01056263** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 52 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

- **DRUG:** axitinib: observational study

## Key facts

- **NCT ID:** NCT01056263
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2012-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01056263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01056263, "Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01056263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*